Laparoscopic spleen surgery for people with cirrhosis
Part of Digestive system clinical trials.
This study looks at whether removing the spleen using keyhole surgery can improve “liver reserve function” in people with cirrhosis. It may be considered for patients who have an enlarged spleen and very low platelets, but it also has several safety exclusions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with cirrhosis (from tests, imaging, or a biopsy)
- Your spleen is enlarged and your platelets are under 50,000 (50×10^9/L)
- You can agree to take part in the study (give informed consent)
- You do not have liver cancer or any other cancer
- Your liver function score is not the worst category (not Child-Pugh C)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a minimally invasive spleen surgery (with a specific vein-disconnection procedure) can better protect liver function in people with cirrhosis who have had variceal bleeding. It may help reduce stress on the liver after treatment, but you must meet several safety criteria.
This study is testing a keyhole surgery to remove part of an enlarged spleen in people with cirrhosis. It aims to improve low blood counts and reduce the risk of further bleeding from stomach or esophagus veins.
This study tests whether removing an enlarged spleen through keyhole surgery can improve kidney function in people with cirrhosis and an overactive spleen. The trial follows patients for two years to see if the surgery helps protect the kidneys.
This study looks at whether removing an enlarged spleen (splenectomy) in people with cirrhosis can improve their blood fat (lipid) levels over two years. It may help those with low blood counts due to an overactive spleen.
This study looks at whether a type of keyhole spleen surgery plus cutting a large vein can improve immune function in people with cirrhosis. It may help reduce immune problems that can happen after complications like bleeding from varices (enlarged veins in the esophagus/stomach).
This study tests a surgery (LSD) in people with liver cirrhosis who have had bleeding from enlarged veins in the food pipe or stomach. It looks at whether the surgery helps improve blood fat levels over two years, which might lower future risks.
Hear when a new Splenectomy; Status trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.